SOX9 and non-small cell lung carcinoma: It is of note that there is a significant correlation between shorter overall survival times of patients and high SOX9 expression in both the early histological stage subgroup (stages I and II) and the late histological stage subgroup (stages III and IV), suggesting that SOX9 may be a useful prognostic marker for all stages of NSCLC.